Coronavirus

Commentary

Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic

The value of innovative medicines has absolutely nothing to do with its cost of production. Yet, not only does this myth persist, it appears to be growing. In the latest example, an article in the Journal of Virus Eradication claims that drugs being repurposed in the hopes they might be effective treatments for ...
Coronavirus

Dr. Henry Miller Talks Supposed Russia COVID-19 vaccine on the Lars Larson Show

Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to get an update on everything COVID-19. Miller and Larson discuss the status of Operation Warp Speed, the Trump Administration’s initiative to develop a coronavirus vaccine. Miller explains that the FDA said they will be very transparent as data and testing ...
Coronavirus

Watch PRI Webinar on Craft Beer, COVID, and Distilleries

On our latest webinar, PRI brings together distillery owners, craft brewers, and licensing experts to examine the impact that COVID-19 has had on the production of our favorite cocktails and beers. The craft beer and distillery industry is one that has seen incredible disruption, with states and counties opening and ...
Commentary

Another coronavirus lockdown would hurt these patients and providers

Last week, National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci urged states with rising COVID-19 rates to consider a new round of lockdown restrictions. “You may need to pause, you may need to drop back a little bit,” Fauci said. “I don’t think you necessarily have to revert to go all the way ...
Blog

Instead of Fining Businesses Government Should Get Its Own House in Order

Last month the state of California began enforcing its expensive and heavy-handed new business privacy laws despite the economic burdens already borne by business because of COVID-19 and the government’s shut down of the economy. At $55 billion in compliance costs with the threat of millions more in penalties and ...
Commentary

Dems use coronavirus to push ‘Medicare-for-all,’ but their ploy is based on bad information

More than 5 million Americans have lost their employer-sponsored health insurance due to coronavirus-related unemployment, according to a new study from FamiliesUSA. In response, Democrats are renewing their push for “Medicare-for-all”. Just this week, 360 Democratic delegates promised to vote against any party platform that doesn’t endorse single-payer health care. In their formal petition, ...
Commentary

COVID-19 makes routine vaccinations more important

As Americans eagerly anticipate a COVID-19 vaccine, there’s troubling new evidence that they’re failing to get inoculated against other infectious diseases. To get vaccination rates back where they need to be, policymakers must remind the public of the importance of routine immunizations and remove the regulatory barriers that make it ...
Blog

Lawmakers Finally Begin to Question Governor’s Executive Powers

A recent survey, conducted by researchers from Harvard and other universities, found that Governor Gavin Newsom’s approval rating had fallen significantly due to the COVID-19 crisis.  As Newsom’s actions provoke increasing opposition from Californians, lawmakers are finally beginning to ask tough questions and demand legislative oversight. State Assemblyman Kevin Kiley ...
Commentary

Don’t Get Too Excited About a Coronavirus Vaccine

There is widespread anticipation of vaccines to prevent COVID-19 infections so life can “get back to normal.” Some three dozen vaccines, made with a variety of technology platforms, or approaches (naked RNA, weakened or killed viruses, hybrid viruses, subunit vaccines, etc.), are now in clinical trials. Many of these vaccine development programs have ...
Commentary

Affordable short-term healthcare plans can flourish thanks to Trump

Millions of people will continue to have access to affordable short-term health plans, thanks to a new ruling from the U.S. District Court of Appeals for the District of Columbia. A three-judge panel of the court upheld by a 2-1 margin a Trump administration rule extending the maximum duration of a short-term plan to ...
Commentary

Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic

The value of innovative medicines has absolutely nothing to do with its cost of production. Yet, not only does this myth persist, it appears to be growing. In the latest example, an article in the Journal of Virus Eradication claims that drugs being repurposed in the hopes they might be effective treatments for ...
Coronavirus

Dr. Henry Miller Talks Supposed Russia COVID-19 vaccine on the Lars Larson Show

Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to get an update on everything COVID-19. Miller and Larson discuss the status of Operation Warp Speed, the Trump Administration’s initiative to develop a coronavirus vaccine. Miller explains that the FDA said they will be very transparent as data and testing ...
Coronavirus

Watch PRI Webinar on Craft Beer, COVID, and Distilleries

On our latest webinar, PRI brings together distillery owners, craft brewers, and licensing experts to examine the impact that COVID-19 has had on the production of our favorite cocktails and beers. The craft beer and distillery industry is one that has seen incredible disruption, with states and counties opening and ...
Commentary

Another coronavirus lockdown would hurt these patients and providers

Last week, National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci urged states with rising COVID-19 rates to consider a new round of lockdown restrictions. “You may need to pause, you may need to drop back a little bit,” Fauci said. “I don’t think you necessarily have to revert to go all the way ...
Blog

Instead of Fining Businesses Government Should Get Its Own House in Order

Last month the state of California began enforcing its expensive and heavy-handed new business privacy laws despite the economic burdens already borne by business because of COVID-19 and the government’s shut down of the economy. At $55 billion in compliance costs with the threat of millions more in penalties and ...
Commentary

Dems use coronavirus to push ‘Medicare-for-all,’ but their ploy is based on bad information

More than 5 million Americans have lost their employer-sponsored health insurance due to coronavirus-related unemployment, according to a new study from FamiliesUSA. In response, Democrats are renewing their push for “Medicare-for-all”. Just this week, 360 Democratic delegates promised to vote against any party platform that doesn’t endorse single-payer health care. In their formal petition, ...
Commentary

COVID-19 makes routine vaccinations more important

As Americans eagerly anticipate a COVID-19 vaccine, there’s troubling new evidence that they’re failing to get inoculated against other infectious diseases. To get vaccination rates back where they need to be, policymakers must remind the public of the importance of routine immunizations and remove the regulatory barriers that make it ...
Blog

Lawmakers Finally Begin to Question Governor’s Executive Powers

A recent survey, conducted by researchers from Harvard and other universities, found that Governor Gavin Newsom’s approval rating had fallen significantly due to the COVID-19 crisis.  As Newsom’s actions provoke increasing opposition from Californians, lawmakers are finally beginning to ask tough questions and demand legislative oversight. State Assemblyman Kevin Kiley ...
Commentary

Don’t Get Too Excited About a Coronavirus Vaccine

There is widespread anticipation of vaccines to prevent COVID-19 infections so life can “get back to normal.” Some three dozen vaccines, made with a variety of technology platforms, or approaches (naked RNA, weakened or killed viruses, hybrid viruses, subunit vaccines, etc.), are now in clinical trials. Many of these vaccine development programs have ...
Commentary

Affordable short-term healthcare plans can flourish thanks to Trump

Millions of people will continue to have access to affordable short-term health plans, thanks to a new ruling from the U.S. District Court of Appeals for the District of Columbia. A three-judge panel of the court upheld by a 2-1 margin a Trump administration rule extending the maximum duration of a short-term plan to ...
Scroll to Top